Scolaris Content Display Scolaris Content Display

Therapeutic interventions for sleep disorders in Parkinson's disease

Referencias

Additional references

Carter 1990

Carter J, Carroll S, Lannon MC. Sleep disruption in untreated Parkinson's disease. Neurology 1990;40(suppl 1):220.

Factor 1990

Factor SA, McAlarney T, Sanchez‐Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Movement Disorders 1990;5:280‐5.

Ferreira 2006

Ferreira JJ, Desboeuf K, Galitzky M, Thalamas C, Brefel‐Courbon C, Fabre N, et al. Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age‐matched healthy volunteers. European Journal of Neurology 2006;13(3):209‐14.

Jansen 1988

Jansen EN, Meerwaldt JD. Madopar HBS in Parkinson patients with nocturnal akinesia. Clinical Neurology and Neurosurgery 1988;90(1):35‐9.

Karlsen 1999

Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 1999;66(4):431‐5.

Leeman 1987

Leeman AL, O'Neill CJ, Nicholson PW, Deshmukh AA, Denham MJ, Royston JP, et al. Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa. British Journal of Clinical Pharmacology 1987;24(5):637‐43.

Lees 1987

Lees AJ. A sustained‐release formulation of L‐dopa (Madopar HBS) in the treatment of nocturnal and early‐morning disabilities in Parkinson's disease. European Neurology 1987;27(suppl 1):126‐34.

Lees 1988

Lees AJ, Blackburn NA, Campbell VL. The night time problems of Parkinson's disease. Clinical Neuropharmacology 1988;11:512‐9.

Lesser 1979

Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barrett RE. Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapy. Neurology 1979;29(9 Pt 1):1253‐60.

Nausieda 1982

Nausieda PA, Weiner WJ, Kaplan LR, Weber S, Klawans HL. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clinical Neuropharmacology 1982;5(2):183‐94.

Parkinson 1817

Parkinson J. An essay on the shaking. London: Whittingham and Rowland, 1817.

Reuter 1999

Reuter I, Ellis CM, Ray Chaudhuri K. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Acta Neurologica Scandinavica 1999;100:163‐7.

Stocchi 1998

Stocchi F, Barbato L, Nordera G, Berardelli A, Ruggieri S. Sleep disorders in Parkinson's disease. Neurology 1998;245 (suppl 1):S15‐8.

Sweet 1975

Sweet RD, McDowell FH. Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients. Annals of Internal Medicine 1975;83(4):456‐63.

Tandberg 1998

Tandberg E, Larsen JP, Karlsen K. A community‐based study of sleep disorders in patients with Parkinson's disease. Movement Disorders 1998;13:895‐9.

Twelves 2003

Twelves D, Perkins K, Counsell C. Systematic review of incidence studies of Parkinson's disease. Movement Disorders 2003;8(1):19‐31.

UK Madopar CR 1989

UK Madopar CR Study Group. A comparison of Madopar CR and standard Madopar in the treatment of nocturnal and early‐morning disability in Parkinson's disease. Clinical Neuropharmacology 1989;12(6):498‐505.

Van Den Eeden 2003

Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. American Journal of Epidemiology 2003;157(11):1015‐22.

Van den Kerchove1993

Van den Kerchove M, Jacquy J, Gonce M, De Deyn PP. Sustained‐release levodopa in parkinsonian patients with nocturnal disabilities. Acta Neurologica Belgica 1993;93(1):32‐9.

van Hilten 1993

van Hilten JJ, Weggeman M, van der Velde EA, Kerkhof GA, van Dijk JG, Roos RAC. Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. Journal of Neural Transmission 1993;5:235‐44.